4.5 Article

Predictors of subjective and objective quality of life in outpatients with schizophrenia

Journal

PSYCHIATRY AND CLINICAL NEUROSCIENCES
Volume 62, Issue 4, Pages 404-411

Publisher

WILEY
DOI: 10.1111/j.1440-1819.2008.01818.x

Keywords

cognitive dysfunction; depressive and negative symptoms; objective quality of life; schizophrenia; subjective quality of life

Ask authors/readers for more resources

Aim: In recent years, greater attention has been given to quality of life (QOL) in schizophrenia and several studies reported that negative and depressive symptoms and cognitive dysfunction are related to patient QOL. But because a variety of QOL measures have been used in the previous studies, there seems to be no unanimous predictors for subjective and objective QOL. The purpose of the present study was to elucidate the relationship between clinical variables and subjective and objective QOL in outpatients with schizophrenia, using schizophrenia disease-specific QOL measures. Particular attention was paid to cognitive function as a predictor of QOL. Methods: Schizophrenia symptoms of the Positive and Negative Syndrome Scale (PANSS) were divided into five factors: positive factor, negative factor, cognitive factor, emotional discomfort, and hostility. The study sample consisted of 84 schizophrenia outpatients. Subjective and objective QOL were assessed with Schizophrenia Quality of Life Scale (SQLS) and the Quality of Life Scale (QLS), respectively. Results: Subjective QOL correlated significantly with emotional discomfort, positive factor, negative factor, extrapyramidal symptoms and cognitive factor, while objective QOL correlated with negative factor, cognitive factor, emotional discomfort, extrapyramidal symptoms, and dose of antipsychotics. Total score and three of four subscales in the QLS correlated significantly with cognitive factor, while cognitive factor had a significant correlation with only one of three scales of SQLS. Stepwise regression showed that subjective QOL was significantly predicted by emotional discomfort and extrapyramidal symptoms, while negative factor was the most important predictor of objective QOL. Conclusion: Cognitive dysfunction had a greater influence on objective QOL than subjective QOL. Treating depressive and negative symptoms and extrapyramidal symptoms might contribute to enhanced subjective and objective QOL.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Geriatrics & Gerontology

Secular trends in the prevalence of dementia based on a community-based complete enumeration in Japan: the Nakayama Study

Hideaki Shimizu, Takaaki Mori, Taku Yoshida, Ayumi Tachibana, Tomoki Ozaki, Yuta Yoshino, Shinichiro Ochi, Naomi Sonobe, Teruhisa Matsumoto, Kenjiro Komori, Jun-ichi Iga, Toshiharu Ninomiya, Shu-ichi Ueno, Manabu Ikeda

Summary: A study shows that the prevalence of dementia is increasing in Japan, which has the world's highest ageing population. This suggests that factors beyond ageing are contributing to the rising number of older people with dementia. To control the increase in dementia cases, it is necessary to study the trends in incidence, mortality, and prognosis of dementia, as well as the factors that promote or protect against dementia, and develop preventive strategies.

PSYCHOGERIATRICS (2022)

Article Psychiatry

Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia

Yu Funahashi, Yuta Yoshino, Jun-ichi Iga, Shu-ichi Ueno

Summary: This study investigated the global expression changes of miRNA in plasma exosomes derived from treatment-resistant schizophrenia patients. The results showed significant upregulation of miR-675-3p expression after clozapine treatment.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2023)

Article Clinical Neurology

Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysis

Takashi Tsuboi, Yoshikazu Takaesu, Naomi Hasegawa, Shinichiro Ochi, Kentaro Fukumoto, Kazutaka Ohi, Hiroyuki Muraoka, Tsuyoshi Okada, Funitoshi Kodaka, Shun Igarashi, Hitoshi Iida, Hiroko Kashiwagi, Hikaru Hori, Kayo Ichihashi, Kazuyoshi Ogasawara, Naoki Hashimoto, Jun-Ichi Iga, Toshinori Nakamura, Masahide Usami, Tatsuya Nagasawa, Mikio Kido, Hiroshi Komatsu, Hirotaka Yamagata, Kiyokazu Atake, Ryuji Furihata, Saya Kikuchi, Tadasu Horai, Masahiro Takeshima, Yoji Hirano, Manabu Makinodan, Junya Matsumoto, Kenichiro Miura, Akitoyo Hishimoto, Shusuke Numata, Hisashi Yamada, Norio Yasui-Furukori, Ken Inada, Koichiro Watanabe, Ryota Hashimoto

Summary: The use of electroconvulsive therapy (ECT) may reduce the need for anxiolytic and sleep medication in patients with major depressive disorder (MDD). However, there was no significant difference in anxiolytic and sleep medication use between the ECT and non-ECT groups in patients with schizophrenia (SZ).

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2023)

Article Neurosciences

MiR-15b-5p Expression in the Peripheral Blood: A Potential Diagnostic Biomarker of Autism Spectrum Disorder

Rie Hosokawa, Yuta Yoshino, Yu Funahashi, Fumie Horiuchi, Jun-ichi Iga, Shu-ichi Ueno

Summary: This study investigates the expression of miRNA and mRNA in peripheral blood to explore a diagnostic biomarker for autism spectrum disorder (ASD). The results suggest that upregulated expression of miR-15b-5p may serve as a useful diagnostic marker for ASD and it may regulate the expression of TGFBR3 mRNA.

BRAIN SCIENCES (2023)

Article Multidisciplinary Sciences

Interferon signaling and hypercytokinemia-related gene expression in the blood of antidepressant non-responders

Hirotaka Yamagata, Ryouichi Tsunedomi, Toshiharu Kamishikiryo, Ayumi Kobayashi, Tomoe Seki, Masaaki Kobayashi, Kosuke Hagiwara, Norihiro Yamada, Chong Chen, Shusaku Uchida, Hiroyuki Ogihara, Yoshihiko Hamamoto, Go Okada, Manabu Fuchikami, Jun-ichi Iga, Shusuke Numata, Makoto Kinoshita, Takahiro A. Kato, Ryota Hashimoto, Hiroaki Nagano, Shuichi Ueno, Yasumasa Okamoto, Tetsuro Ohmori, Shin Nakagawa

Summary: By studying biomarkers for predicting antidepressant responses, we identified genes associated with antidepressant responsiveness and confirmed their differential expression through molecular biology experiments. Further research indicated an association between antidepressant responses and inflammation, which could be valuable for future treatment strategies for depression.

HELIYON (2023)

Article Neurosciences

Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project

Hitoshi Iida, Tsuyoshi Okada, Kiyotaka Nemoto, Naomi Hasegawa, Shusuke Numata, Kazuyoshi Ogasawara, Kenichiro Miura, Junya Matsumoto, Hikaru Hori, Jun-ichi Iga, Kayo Ichihashi, Naoki Hashimoto, Hisashi Yamada, Kazutaka Ohi, Norio Yasui-Furukori, Kentaro Fukumoto, Takashi Tsuboi, Masahide Usami, Ryuji Furihata, Yoshikazu Takaesu, Akitoyo Hishimoto, Hiroyuki Muraoka, Eiichi Katsumoto, Tatsuya Nagasawa, Shinichiro Ochi, Hiroshi Komatsu, Saya Kikuchi, Masahiro Takeshima, Toshiaki Onitsuka, Shinichiro Tamai, Chika Kubota, Ken Inada, Koichiro Watanabe, Hiroaki Kawasaki, Ryota Hashimoto

Summary: The EGUIDE project was launched in 2016 to disseminate, educate, and validate psychiatric clinical practice guidelines. This study compared the effectiveness of web-based courses and face-to-face courses offered by the project. The results showed that web-based courses were rated as more satisfying than expected and there were no significant differences in satisfaction and clinical knowledge between the two formats. This suggests that web-based courses could be widely adopted alongside face-to-face courses after the COVID-19 pandemic.

NEUROPSYCHOPHARMACOLOGY REPORTS (2023)

Article Urology & Nephrology

CKD, Brain Atrophy, and White Matter Lesion Volume: The Japan Prospective Studies Collaboration for Aging and Dementia

Kenji Maki, Tomoyuki Ohara, Jun Hata, Mao Shibata, Naoki Hirabayashi, Takanori Honda, Satoko Sakata, Yoshihiko Furuta, Masato Akiyama, Keisuke Yamasaki, Yasuko Tatewaki, Yasuyuki Taki, Takanari Kitazono, Tatsuya Mikami, Tetsuya Maeda, Kenjiro Ono, Masaru Mimura, Kenji Nakashima, Jun-ichi Iga, Minoru Takebayashi, Toshiharu Ninomiya

Summary: This study aimed to examine the associations between urinary albumin-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) levels with brain atrophy and white matter lesion volume (WMLV) in a large-scale community-dwelling older population of Japanese. The results showed that higher UACR levels were significantly associated with lower total brain volume-to-intracranial volume ratio (TBV/ICV) and higher WMLV-to-ICV ratio. Lower eGFR levels were associated with lower TBV/ICV, but not clearly associated with WMLV/ICV. Higher UACR levels were also associated with lower regional brain volume-to-TBV ratio and lower hippocampal volume-to-TBV ratio.

KIDNEY MEDICINE (2023)

Article Neurosciences

Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer's Disease

Hiroaki Mori, Yuta Yoshino, Jun-ichi Iga, Shinichiro Ochi, Yu Funahashi, Kiyohiro Yamazaki, Hiroshi Kumon, Yuki Ozaki, Shu-ichi Ueno

Summary: In this study, the gene expression levels in the brain of 3xTg-AD model mice were explored to understand the molecular pathological changes of Alzheimer's disease (AD) from early to late stages. The study found changes in immune response and GABAergic neurotransmission in the brain of the mice from early to late stages of AD.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Pharmacology & Pharmacy

Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics A Nationwide Real-World Study in Japan

Toshiaki Onitsuka, Tsuyoshi Okada, Naomi Hasegawa, Takashi Tsuboi, Jun-ichi Iga, Norio Yasui-Furukori, Naoki Yamada, Hikaru Hori, Hiroyuki Muraoka, Kazutaka Ohi, Kazuyoshi Ogasawara, Shinichiro Ochi, Masahiro Takeshima, Kayo Ichihashi, Kentaro Fukumoto, Hitoshi Iida, Hisashi Yamada, Ryuji Furihata, Manabu Makinodan, Yoshikazu Takaesu, Shusuke Numata, Hiroshi Komatsu, Akitoyo Hishimoto, Mikio Kido, Kiyokazu Atake, Hirotaka Yamagata, Saya Kikuchi, Naoki Hashimoto, Masahide Usami, Eiichi Katsumoto, Takeshi Asami, Chika Kubota, Junya Matsumoto, Kenichiro Miura, Yoji Hirano, Koichiro Watanabe, Ken Inada, Ryota Hashimoto

Summary: This study investigated the use of psychotropic medications among schizophrenia patients in Japan who received long-acting injectable antipsychotics (LAIs) or oral antipsychotics (OAPs). The results showed that the LAI group had higher rates of polypharmacy antipsychotics, number of antipsychotics, and chlorpromazine equivalents compared to the non-LAI group. However, the LAI group had a lower rate of concomitant use of hypnotic and/or antianxiety medication than the non-LAI group. The study concluded that clinicians should consider monotherapy for the treatment of schizophrenia, especially by reducing concomitant use of antipsychotics in the LAI group and reducing hypnotic and/or antianxiety medication in the non-LAI group.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2023)

Article Psychiatry

Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project

Naoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, Shuhei Ishikawa, Hikaru Hori, Hitoshi Iida, Kayo Ichihashi, Kenichiro Miura, Junya Matsumoto, Shusuke Numata, Fumitoshi Kodaka, Ryuji Furihata, Kazutaka Ohi, Kazuyoshi Ogasawara, Jun-ichi Iga, Hiroyuki Muraoka, Hiroshi Komatsu, Masahiro Takeshima, Kiyokazu Atake, Mikio Kido, Toshinori Nakamura, Taishiro Kishimoto, Akitoyo Hishimoto, Toshiaki Onitsuka, Tsuyoshi Okada, Shinichiro Ochi, Tatsuya Nagasawa, Manabu Makinodan, Hiroki Yamada, Takashi Tsuboi, Hisashi Yamada, Ken Inada, Koichiro Watanabe, Ryota Hashimoto

Summary: The study aimed to compare psychotropic prescriptions in Japan between hospital admission and discharge, aligning them with international standards and reducing facility differences. Patients who received monotherapy with the main drug at admission were likely to continue with monotherapy at discharge. Polypharmacy was more common in patients who switched from monotherapy to polypharmacy. Over 10% of patients had no changes in prescription throughout their hospital stay.

BMC PSYCHIATRY (2023)

Article Neurosciences

Gestational exposure to haloperidol changes Cdkn1a and Apaf1 mRNA expressions in mouse hippocampus

Hiroshi Kumon, Yuta Yoshino, Tomoki Ozaki, Yu Funahashi, Hiroaki Mori, Mariko Ueno, Yuki Ozaki, Kiyohiro Yamazaki, Shinichiro Ochi, Jun-ichi Iga, Shu-ichi Ueno

Summary: This study aimed to replicate previous research and focused on apoptotic-related gene expression changes in fetal brains exposed to haloperidol during pregnancy. Using RNA sequencing and qPCR methods, the up-regulation of Cdkn1a and Apaf1 mRNA expression in the hippocampus of offspring was successfully validated, and the dose-dependent upregulation of both mRNA expressions by haloperidol and aripiprazole was confirmed in in vitro experiments.

BRAIN RESEARCH BULLETIN (2023)

Article Geriatrics & Gerontology

Late-Life High Blood Pressure and Enlarged Perivascular Spaces in the Putaminal Regions of Community-Dwelling Japanese Older Persons

Ayumi Tachibana, Jun-ichi Iga, Yasuko Tatewaki, Benjamin Thyreau, Hongkun Chen, Tomoki Ozaki, Taku Yoshida, Yuta Yoshino, Hideaki Shimizu, Takaaki Mori, Yoshihiko Furuta, Mao Shibata, Tomoyuki Ohara, Jun Hata, Yasuyuki Taki, Shigeyuki Nakaji, Tetsuya Maeda, Kenjiro Ono, Masaru Mimura, Kenji Nakashima, Minoru Takebayashi, Toshiharu Ninomiya, Shu-ichi Ueno

Summary: The aim of this study was to determine the association between blood pressure (BP) and enlarged perivascular spaces (EPVS) volumes, and to examine the interactions of relevant factors. The study found a significant association between higher blood pressure levels and greater EPVS volumes in cognitively normal older people, and this association persisted even after excluding subjects with dementia.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2023)

Article Clinical Neurology

Association Between Frequency of Social Contact and Brain Atrophy in Community-Dwelling Older People Without Dementia

Naoki Hirabayashi, Takanori Honda, Jun Hata, Yoshihiko Furuta, Mao Shibata, Tomoyuki Ohara, Yasuko Tatewaki, Yasuyuki Taki, Shigeyuki Nakaji, Tetsuya Maeda, Kenjiro Ono, Masaru Mimura, Kenji Nakashima, Jun-ichi Iga, Minoru Takebayashi, Toshiharu Ninomiya

Summary: Low frequency of social contact is associated with brain atrophy, and depressive symptoms play a role in this relationship.

NEUROLOGY (2023)

Article Geriatrics & Gerontology

Analysis of factors related to cognitive impairment in a community-based, complete enumeration survey in Japan: the Nakayama study

Taku Yoshida, Takaaki Mori, Hideaki Shimizu, Ayumi Tachibana, Yuta Yoshino, Shinichiro Ochi, Kiyohiro Yamazaki, Yuki Ozaki, Kentaro Kawabe, Fumie Horiuchi, Kenjiro Komori, Jun-ichi Iga, Shu-ichi Ueno

Summary: This study aimed to identify risk and protective factors for cognitive disorders and found that diabetes mellitus, low activities of daily living, and living alone are risk factors for cognitive decline, while exercise and drinking habits are protective factors.

PSYCHOGERIATRICS (2023)

Article Geriatrics & Gerontology

Gender and age influence the association between gait speed and mild cognitive impairment in community-dwelling Japanese older adults: from the Japan Prospective Studies Collaboration for Ageing and Dementia (JPSC-AD)

Shogyoku Bun, Kouta Suzuki, Hidehito Niimura, Ryo Shikimoto, Hisashi Kida, Mao Shibata, Takanori Honda, Tomoyuki Ohara, Jun Hata, Shigeyuki Nakaji, Tetsuya Maeda, Kenjiro Ono, Kenji Nakashima, Jun-ichi Iga, Minoru Takebayashi, Toshiharu Ninomiya, Masaru Mimura, JPSC-AD Study Grp

Summary: The association between decreased gait speed and impaired cognitive function was examined, with a focus on the influence of age and gender in the older population. Results showed that reduced gait speed was associated with increased odds of mild cognitive impairment (MCI), and this association may vary according to gender and age.

PSYCHOGERIATRICS (2023)

No Data Available